Travere Therapeutics, Inc. (TVTX)
USD 14.51
(-3.2%)
USD 14.51
(-3.2%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -326.24 Million USD | -35.82% |
| 2022 | -299.42 Million USD | -77.96% |
| 2021 | -186.67 Million USD | -99.09% |
| 2020 | -143.95 Million USD | 1.01% |
| 2019 | -107.21 Million USD | -9.41% |
| 2018 | -73.38 Million USD | -114.46% |
| 2017 | -38.67 Million USD | -326.05% |
| 2016 | -38.78 Million USD | 78.98% |
| 2015 | 129.45 Million USD | 37.41% |
| 2014 | -74.1 Million USD | -277.65% |
| 2013 | -34.28 Million USD | 53.42% |
| 2012 | -30.11 Million USD | -234678.18% |
| 2011 | -12.82 Thousand USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 100.0% |
| 2008 | -18.26 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -122.82 Million USD | -66.66% |
| 2024 Q3 | -54.75 Million USD | 27.67% |
| 2024 Q2 | -56.7 Million USD | 54.15% |
| 2023 Q4 | -70.98 Million USD | 20.45% |
| 2023 Q2 | -66.91 Million USD | 0.15% |
| 2023 Q3 | -89.24 Million USD | -33.37% |
| 2023 FY | - USD | -35.82% |
| 2023 Q1 | -67.01 Million USD | -3.06% |
| 2022 Q3 | -54.86 Million USD | -7.59% |
| 2022 Q4 | -65.02 Million USD | -18.53% |
| 2022 FY | - USD | -77.96% |
| 2022 Q2 | -50.99 Million USD | -2.69% |
| 2022 Q1 | -49.65 Million USD | -3.02% |
| 2021 FY | - USD | -99.09% |
| 2021 Q4 | -48.2 Million USD | -437.95% |
| 2021 Q1 | -33.57 Million USD | -66.2% |
| 2021 Q2 | -25.98 Million USD | 22.61% |
| 2021 Q3 | -8.96 Million USD | 65.51% |
| 2020 Q4 | -20.2 Million USD | -223.98% |
| 2020 Q3 | -6.23 Million USD | 44.49% |
| 2020 Q1 | -7.62 Million USD | 31.36% |
| 2020 Q2 | -11.23 Million USD | -47.3% |
| 2020 FY | - USD | 1.01% |
| 2019 Q3 | -17.46 Million USD | 42.66% |
| 2019 FY | - USD | -9.41% |
| 2019 Q1 | -25.04 Million USD | -89.9% |
| 2019 Q2 | -30.46 Million USD | -21.64% |
| 2019 Q4 | -11.1 Million USD | 36.4% |
| 2018 Q1 | -9.81 Million USD | -69.07% |
| 2018 FY | - USD | -114.46% |
| 2018 Q4 | -13.18 Million USD | -0.46% |
| 2018 Q3 | -13.12 Million USD | 33.72% |
| 2018 Q2 | -19.8 Million USD | -101.75% |
| 2017 Q3 | 125 Thousand USD | 102.27% |
| 2017 Q1 | -6.65 Million USD | -165.4% |
| 2017 FY | - USD | -326.05% |
| 2017 Q4 | -5.8 Million USD | -4744.8% |
| 2017 Q2 | -5.49 Million USD | 17.42% |
| 2016 Q1 | -1.44 Million USD | 83.55% |
| 2016 Q3 | -10.87 Million USD | -125.1% |
| 2016 FY | - USD | 78.98% |
| 2016 Q4 | 10.17 Million USD | 193.6% |
| 2016 Q2 | -4.82 Million USD | -234.19% |
| 2015 FY | - USD | 37.41% |
| 2015 Q4 | -8.78 Million USD | 4.48% |
| 2015 Q1 | -6.92 Million USD | -176.07% |
| 2015 Q3 | -9.19 Million USD | -43.16% |
| 2015 Q2 | -6.42 Million USD | 7.27% |
| 2014 Q4 | 9.1 Million USD | 142.14% |
| 2014 FY | - USD | -277.65% |
| 2014 Q1 | 36.78 Million USD | 2288.22% |
| 2014 Q2 | -53.85 Million USD | -246.4% |
| 2014 Q3 | -21.6 Million USD | 59.88% |
| 2013 Q4 | -1.68 Million USD | 67.04% |
| 2013 FY | - USD | 53.42% |
| 2013 Q1 | -2.19 Million USD | -69444.95% |
| 2013 Q2 | -5.04 Million USD | -129.57% |
| 2013 Q3 | -5.1 Million USD | -1.07% |
| 2012 Q2 | -3009.00 USD | 19.93% |
| 2012 FY | - USD | -234678.18% |
| 2012 Q3 | -3000.00 USD | 0.3% |
| 2012 Q4 | -3161.00 USD | -5.37% |
| 2012 Q1 | -3758.00 USD | -24.52% |
| 2011 Q1 | -3580.00 USD | -15.82% |
| 2011 Q2 | -3024.00 USD | 15.53% |
| 2011 Q3 | -3525.00 USD | -16.57% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | -3018.00 USD | 14.38% |
| 2010 Q2 | -6644.00 USD | -131.66% |
| 2010 Q4 | -3091.00 USD | 53.35% |
| 2010 Q3 | -6626.00 USD | 0.27% |
| 2010 Q1 | 20.98 Thousand USD | 415.82% |
| 2010 FY | - USD | 0.0% |
| 2009 Q2 | -7645.00 USD | 0.0% |
| 2009 Q4 | -6644.00 USD | 0.75% |
| 2009 Q3 | -6694.00 USD | 12.44% |
| 2009 FY | - USD | 100.0% |
| 2008 Q2 | -3376.00 USD | 0.0% |
| 2008 Q3 | -3050.00 USD | 9.66% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | -4251.00 USD | -39.38% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -69.78% |
| Alkermes plc | 495.04 Million USD | 165.902% |
| Agenus Inc. | -145.92 Million USD | -123.573% |
| Aptorum Group Limited | -9.59 Million USD | -3298.751% |
| Ardelyx, Inc. | -55.35 Million USD | -489.381% |
| Dyadic International, Inc. | -8.22 Million USD | -3864.233% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -112012.027% |
| Lantern Pharma Inc. | -15.78 Million USD | -1966.589% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -1538.407% |
| Novavax, Inc. | -487.39 Million USD | 33.063% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -359.346% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -315.637% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -1715.155% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -3172.933% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -468.611% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 14.139% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1253.05% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 61772.212% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -107.542% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -336.071% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -1518.364% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -1274.535% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -1314.893% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -167.189% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -26.333% |
| AlloVir, Inc. | -190.14 Million USD | -71.577% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -85.713% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1015.066% |
| Bicycle Therapeutics plc | -183.4 Million USD | -77.888% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -97.222% |
| ChromaDex Corporation | -3.89 Million USD | -8278.172% |
| Chimerix, Inc. | -92.97 Million USD | -250.9% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -634.181% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -189.909% |
| CRISPR Therapeutics AG | -202.7 Million USD | -60.949% |
| Precision BioSciences, Inc. | -32.04 Million USD | -918.182% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -89.426% |
| Fortress Biotech, Inc. | -133.64 Million USD | -144.118% |
| Fortress Biotech, Inc. | -133.64 Million USD | -144.118% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -321.817% |
| ImmuCell Corporation | -2.5 Million USD | -12928.593% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -150.148% |
| Immix Biopharma, Inc. | -16.13 Million USD | -1921.896% |
| Incyte Corporation | 919.42 Million USD | 135.484% |
| Innoviva, Inc. | 248.96 Million USD | 231.044% |
| IO Biotech, Inc. | -91.22 Million USD | -257.616% |
| Jaguar Health, Inc. | -33.13 Million USD | -884.715% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -114.386% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 420.707% |
| ContextLogic Inc. | -324 Million USD | -0.693% |
| MiMedx Group, Inc. | 40.51 Million USD | 905.208% |
| MEI Pharma, Inc. | 26.38 Million USD | 1336.717% |
| NextCure, Inc. | -59.03 Million USD | -452.594% |
| Onconetix, Inc. | -36.7 Million USD | -788.791% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 14697.136% |
| Opthea Limited | -200.01 Million USD | -63.108% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -11756.679% |
| Vaxcyte, Inc. | -464.88 Million USD | 29.822% |
| PDS Biotechnology Corporation | -40.08 Million USD | -713.886% |
| Precigen, Inc. | -89.22 Million USD | -265.64% |
| Pharming Group N.V. | 9.87 Million USD | 3403.088% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -105.123% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -1333.292% |
| PureTech Health plc | -11.62 Million USD | -2705.934% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -1821.241% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -39.722% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1253.05% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -273.164% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1026.423% |
| Acelyrin, Inc. | -381.52 Million USD | 14.489% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -2531904.542% |
| Summit Therapeutics Inc. | 1 Million USD | 32692.008% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -877.194% |
| Senti Biosciences, Inc. | -61.33 Million USD | -431.9% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -190.503% |
| Elevation Oncology, Inc. | -41.46 Million USD | -686.761% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -955.676% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -5233.827% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -101534.268% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -905.288% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -3785.731% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -454.935% |
| Seer, Inc. | -97.88 Million USD | -233.295% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -424.537% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -399.114% |
| ESSA Pharma Inc. | -26.45 Million USD | -1133.197% |
| GlycoMimetics, Inc. | -39.12 Million USD | -733.92% |
| GT Biopharma, Inc. | 5.97 Million USD | 5556.531% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -57.841% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -4650.233% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 475.807% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -474.842% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -536.963% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -3199.779% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 39.576% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -4639.192% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -596.185% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -37.876% |
| Aptose Biosciences Inc. | -52.26 Million USD | -524.179% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -202.799% |
| Soligenix, Inc. | -7.85 Million USD | -4054.492% |
| Century Therapeutics, Inc. | -121.2 Million USD | -169.162% |
| Kura Oncology, Inc. | -164.95 Million USD | -97.779% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -307.309% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -3134.642% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -33964.187% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -7471.269% |
| Autolus Therapeutics plc | -156.77 Million USD | -108.105% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -285.374% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -372.813% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -1536.631% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -72.368% |
| GRI Bio, Inc. | -10.89 Million USD | -2893.632% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -7124.681% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -166.31% |
| IGM Biosciences, Inc. | -253.35 Million USD | -28.769% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -214.327% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -755.543% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2028.028% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -1972.292% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -473.922% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -204.61% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -22.65% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -68.221% |
| Verastem, Inc. | -83.16 Million USD | -292.283% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -545.112% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -106.187% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -185.957% |
| Histogen Inc. | -10.5 Million USD | -3006.217% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -2184.683% |
| Surrozen, Inc. | -41.13 Million USD | -693.188% |
| Organovo Holdings, Inc. | -14.8 Million USD | -2103.472% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 10173034.206% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -455.661% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -536.032% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -1414.676% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -3812.759% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -96.455% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -562.315% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1250.021% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -2067.022% |
| Apollomics, Inc. | -171.74 Million USD | -89.957% |
| Amarin Corporation plc | -50.9 Million USD | -540.936% |
| Mesoblast Limited | -61.33 Million USD | -431.943% |
| Turnstone Biologics Corp. | -56.23 Million USD | -480.158% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -127.824% |
| Synaptogenix, Inc. | -8.3 Million USD | -3827.123% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -2026.905% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -417.465% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -6708.897% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 76141.106% |
| Exelixis, Inc. | 196.6 Million USD | 265.942% |
| Better Therapeutics, Inc. | -38.26 Million USD | -752.663% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -130.711% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 34.12% |
| NLS Pharmaceutics AG | -11.79 Million USD | -2665.815% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 132067.996% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -1005.694% |
| Gritstone bio, Inc. | -126.86 Million USD | -157.164% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -402.033% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -8056.26% |
| Avid Bioservices, Inc. | -11.48 Million USD | -2741.617% |
| Insmed Incorporated | -654.73 Million USD | 50.172% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -14401.633% |
| MediWound Ltd. | -4.89 Million USD | -6567.607% |
| OmniAb, Inc. | -49.73 Million USD | -556.021% |
| Alector, Inc. | -142.89 Million USD | -128.316% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -281.869% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -525.616% |
| Zai Lab Limited | -366.57 Million USD | 11.001% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -12.252% |
| Aura Biosciences, Inc. | -83.69 Million USD | -289.799% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -44.838% |
| Immunic, Inc. | -99.11 Million USD | -229.169% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -147.775% |
| Veracyte, Inc. | -49.4 Million USD | -560.297% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -4518.477% |
| FibroGen, Inc. | -261.4 Million USD | -24.805% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -2828.337% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -4559.773% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -1643.059% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 122.509% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1183.322% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 917.864% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1349.985% |
| Galecto, Inc. | -37.51 Million USD | -769.549% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -752.596% |
| Fortrea Holdings Inc. | 167.3 Million USD | 295.007% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -142.959% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1052.365% |
| XBiotech Inc. | -35.76 Million USD | -812.168% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -402.033% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -399.994% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -212.332% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1170.824% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -698.312% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 36.83% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -482.364% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -581952.06% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -180.437% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -1371.595% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -38.79% |
| NexImmune, Inc. | -28.16 Million USD | -1058.235% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -5804.319% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -2666.609% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 107.01% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1184.838% |
| Scopus BioPharma Inc. | -11.71 Million USD | -2685.297% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -159.242% |
| Ainos, Inc. | -8.77 Million USD | -3618.709% |
| Pluri Inc. | -20.22 Million USD | -1513.083% |
| Prothena Corporation plc | -190.1 Million USD | -71.611% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -154.486% |
| Celularity Inc. | -183.94 Million USD | -77.36% |
| Rallybio Corporation | -72.37 Million USD | -350.784% |
| Cue Biopharma, Inc. | -46.05 Million USD | -608.43% |
| MeiraGTx Holdings plc | -57.05 Million USD | -471.84% |
| Omeros Corporation | -163.61 Million USD | -99.405% |
| Humacyte, Inc. | -96.45 Million USD | -238.226% |
| Immunocore Holdings plc | -59.64 Million USD | -446.943% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -1584.111% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1238.994% |
| Blueprint Medicines Corporation | -474.61 Million USD | 31.26% |
| CalciMedica, Inc. | -34.18 Million USD | -854.243% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -345.484% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -159.963% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -93.674% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -29.263% |
| Pulmatrix, Inc. | -12.64 Million USD | -2479.836% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -889.644% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -268.777% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 35.565% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -222.33% |
| Cytokinetics, Incorporated | -456.68 Million USD | 28.562% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -877.575% |
| Nutriband Inc. | -5.12 Million USD | -6269.781% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -653.943% |
| Vor Biopharma Inc. | -114.37 Million USD | -185.252% |
| Roivant Sciences Ltd. | -996.51 Million USD | 67.261% |
| Evogene Ltd. | -23.2 Million USD | -1305.99% |
| ProKidney Corp. | -147.66 Million USD | -120.931% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -405.533% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -212925.224% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 42.305% |
| CorMedix Inc. | -48.88 Million USD | -567.347% |
| BioLineRx Ltd. | -57.06 Million USD | -471.75% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -191.922% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -161407.921% |
| Atai Life Sciences N.V. | -36.31 Million USD | -798.477% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -310.285% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -301.222% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -18.418% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -961.308% |
| MediciNova, Inc. | -9.87 Million USD | -3202.095% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -159.047% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -21220.467% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1123.326% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -45.004% |
| Biomea Fusion, Inc. | -124.62 Million USD | -161.793% |
| PTC Therapeutics, Inc. | -330.34 Million USD | 1.239% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1152.095% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -71.403% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -41.882% |
| Absci Corporation | -95.45 Million USD | -241.773% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -986.581% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -204.567% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -39.734% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -1327.46% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -56.973% |
| Allakos Inc. | -189.91 Million USD | -71.785% |
| Imunon, Inc. | -19.87 Million USD | -1541.219% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -200.71% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 401.176% |
| BioAtla, Inc. | -122.24 Million USD | -166.888% |
| NLS Pharmaceutics AG | -11.79 Million USD | -2665.815% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -1969.957% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -8.643% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -687.14% |
| XOMA Corporation | -39.36 Million USD | -728.835% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -228.698% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -177.302% |
| aTyr Pharma, Inc. | -52.17 Million USD | -525.256% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -289.245% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -119.501% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -39.086% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -2289.555% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -3956.626% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1841.709% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 172985.865% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 172.187% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -5006.67% |
| UroGen Pharma Ltd. | -63.83 Million USD | -411.109% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -380.374% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -4391.883% |
| Orgenesis Inc. | -60.71 Million USD | -437.313% |
| Entera Bio Ltd. | -8.8 Million USD | -3605.657% |
| GH Research PLC | -41.15 Million USD | -692.764% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1178.444% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -296.734% |
| Xencor, Inc. | -125.87 Million USD | -159.185% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -22769.661% |
| Replimune Group, Inc. | -230.19 Million USD | -41.724% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -1518.475% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -2881.594% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -5006.67% |
| Portage Biotech Inc. | -18.19 Million USD | -1692.659% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -21220.467% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -211.946% |
| OncoCyte Corporation | -23.12 Million USD | -1310.916% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -2787.04% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -2747.609% |
| Purple Biotech Ltd. | -22.22 Million USD | -1367.924% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -4989.641% |
| scPharmaceuticals Inc. | -46.06 Million USD | -608.291% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -1731.846% |
| HilleVax, Inc. | -132.46 Million USD | -146.287% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -2968.24% |
| Tharimmune, Inc. | -9.3 Million USD | -3407.045% |
| Genprex, Inc. | -31.06 Million USD | -950.354% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -73.974% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -940.524% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -42602.356% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 216294.402% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2071846.485% |
| Savara Inc. | -59.13 Million USD | -451.716% |
| Curis, Inc. | -45.13 Million USD | -622.759% |
| Daré Bioscience, Inc. | -30.7 Million USD | -962.638% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -2047.606% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -4453.329% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1120.341% |
| BeiGene, Ltd. | -1.12 Billion USD | 70.99% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -1901.362% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 24.231% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -261.131% |
| Erasca, Inc. | -121.31 Million USD | -168.936% |
| bluebird bio, Inc. | -167.16 Million USD | -95.169% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -7151.916% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 205.144% |
| DBV Technologies S.A. | -85.98 Million USD | -279.435% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -7151.916% |
| Moderna, Inc. | -3.28 Billion USD | 90.063% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -665.674% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -5676.31% |
| Molecular Templates, Inc. | 1.43 Million USD | 22914.406% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -445.088% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -137.981% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -588.777% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -134.652% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -58.48% |
| MacroGenics, Inc. | 2.01 Million USD | 16274.814% |
| RenovoRx, Inc. | -11.39 Million USD | -2764.32% |
| Adicet Bio, Inc. | -136.53 Million USD | -138.947% |
| Prime Medicine, Inc. | -193.75 Million USD | -68.377% |
| Aditxt, Inc. | -25.45 Million USD | -1181.509% |
| Adagene Inc. | -14.95 Million USD | -2082.133% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4362.95% |
| Quantum-Si incorporated | -91.8 Million USD | -255.372% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 145.795% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 357.994% |
| SciSparc Ltd. | -5.28 Million USD | -6076.562% |
| Vericel Corporation | 2.86 Million USD | 11491.271% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -342566.583% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -1404.032% |
| Generation Bio Co. | -133.3 Million USD | -144.746% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -292.925% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -279.254% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -43.446% |
| Invivyd, Inc. | -196.61 Million USD | -65.931% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 12.804% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -3417.554% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1301.466% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -3072.056% |
| 2seventy bio, Inc. | -206.41 Million USD | -58.051% |
| ADMA Biologics, Inc. | 5.12 Million USD | 6471.992% |
| Clene Inc. | -43.24 Million USD | -654.483% |
| Capricor Therapeutics, Inc. | -23 Million USD | -1317.907% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -572.991% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1123.326% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -8.906% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -788.243% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 1483.982% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 6744.176% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -904.39% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -105.958% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 52.324% |
| Evaxion Biotech A/S | -21.4 Million USD | -1424.3% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -391.223% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -49.882% |
| Trevena, Inc. | -35.28 Million USD | -824.524% |
| Surrozen, Inc. | -41.13 Million USD | -693.188% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -309.898% |
| Cingulate Inc. | -22.95 Million USD | -1321.425% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -4272.685% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -775.053% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -3865.856% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -219.017% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -380.997% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -458.908% |
| Clearmind Medicine Inc. | -8.71 Million USD | -3645.364% |
| Kronos Bio, Inc. | -121.83 Million USD | -167.788% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -338.845% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -13262.994% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -223.57% |
| Statera Biopharma, Inc. | 38.93 Million USD | 937.926% |
| ImmunityBio, Inc. | -436.18 Million USD | 25.204% |
| Korro Bio, Inc. | -80.9 Million USD | -303.251% |
| Kineta, Inc. | -15.71 Million USD | -1976.149% |
| BioVie Inc. | -31.95 Million USD | -921.108% |
| Codexis, Inc. | -49.28 Million USD | -561.985% |
| Celularity Inc. | -183.94 Million USD | -77.36% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -47.283% |
| Celcuity Inc. | -58.3 Million USD | -459.503% |
| Virax Biolabs Group Limited | -6.6 Million USD | -4836.282% |
| Cibus, Inc. | -314.58 Million USD | -3.707% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -867.142% |
| IN8bio, Inc. | -28.5 Million USD | -1044.562% |
| Kodiak Sciences Inc. | -259.02 Million USD | -25.953% |
| Annexon, Inc. | -141.57 Million USD | -130.44% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -189.741% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -408.203% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1067.04% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -41.84% |
| Eyenovia, Inc. | -24.1 Million USD | -1253.379% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 828.488% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -100593.21% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -342.044% |
| Arcellx, Inc. | -64.14 Million USD | -408.607% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -624.766% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -164.218% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -956.428% |
| Moolec Science SA | -52.07 Million USD | -526.486% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -532.186% |
| Geron Corporation | -174.78 Million USD | -86.659% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -707.2% |
| Royalty Pharma plc | 1.88 Billion USD | 117.287% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -172.797% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -3398.897% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -1472.971% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -96.439% |
| Humacyte, Inc. | -96.45 Million USD | -238.226% |
| Structure Therapeutics Inc. | -102.45 Million USD | -218.416% |
| 89bio, Inc. | -134.46 Million USD | -142.629% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -313.624% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 8151.481% |
| Genelux Corporation | -24.16 Million USD | -1250.077% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -865.225% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -99.583% |
| Notable Labs, Ltd. | -14.4 Million USD | -2165.597% |
| Liquidia Corporation | -70.05 Million USD | -365.726% |
| Mustang Bio, Inc. | -48.06 Million USD | -578.788% |
| Immunovant, Inc. | -269.97 Million USD | -20.842% |
| Quantum-Si incorporated | -91.8 Million USD | -255.372% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -359.592% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -1589.693% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -219.811% |
| Acasti Pharma Inc. | -11.3 Million USD | -2786.877% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -1366.061% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2028.028% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -54.977% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -7539.808% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -1954.446% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1033.743% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -781.032% |
| PepGen Inc. | -83.58 Million USD | -290.33% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1005.769% |
| United Therapeutics Corporation | 1.38 Billion USD | 123.525% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1324.842% |
| Solid Biosciences Inc. | -93.43 Million USD | -249.173% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -6737.05% |
| Immuneering Corporation | -58.06 Million USD | -461.904% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 10173034.206% |
| Silo Pharma, Inc. | -3.62 Million USD | -8896.877% |
| Belite Bio, Inc | -31.52 Million USD | -934.749% |
| XOMA Corporation | -39.36 Million USD | -728.835% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -383.707% |
| Bionomics Limited | -9.83 Million USD | -3216.521% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -288.457% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -842.744% |
| uniQure N.V. | -253.1 Million USD | -28.9% |
| Cassava Sciences, Inc. | -95.68 Million USD | -240.951% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4362.95% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -151.92% |
| Forte Biosciences, Inc. | -32.47 Million USD | -904.545% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -3952.507% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1056.122% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -100593.21% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -2828.337% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -1951.733% |
| Altimmune, Inc. | -87.93 Million USD | -271.008% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -254.311% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -842.744% |
| Compugen Ltd. | -12.51 Million USD | -2506.632% |
| Peak Bio, Inc. | -1356.23 USD | -24055259.342% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -571.316% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1350.627% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -34.644% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1042.998% |
| Zura Bio Limited | -60.56 Million USD | -438.689% |
| PolyPid Ltd. | -20.26 Million USD | -1510.058% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -1989.579% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1042.998% |
| Instil Bio, Inc. | -146.12 Million USD | -123.27% |
| argenx SE | -216.02 Million USD | -51.024% |
| Immunome, Inc. | -28.27 Million USD | -1053.995% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -573.047% |
| Verona Pharma plc | -52.46 Million USD | -521.805% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -244.243% |
| Shattuck Labs, Inc. | -87.61 Million USD | -272.363% |
| CervoMed Inc. | -2.17 Million USD | -14921.405% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -166.881% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -2470.283% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -577.224% |
| Moolec Science SA | -52.07 Million USD | -526.486% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -1803.421% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -150.206% |
| AnaptysBio, Inc. | -143.16 Million USD | -127.883% |
| Design Therapeutics, Inc. | -66.32 Million USD | -391.89% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -302.837% |
| NeurAxis, Inc. | -6.66 Million USD | -4795.285% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -764.228% |
| Lumos Pharma, Inc. | -36.57 Million USD | -792.114% |
| Achilles Therapeutics plc | -70.44 Million USD | -363.141% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -244.243% |
| 180 Life Sciences Corp. | -22.13 Million USD | -1373.957% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 5696.709% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -13262.994% |
| Nutriband Inc. | -5.12 Million USD | -6269.781% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -197.268% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -488.552% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -545.393% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -399.787% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -502.932% |
| Palisade Bio, Inc. | -12.28 Million USD | -2556.51% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -618.984% |
| Beam Therapeutics Inc. | -156.47 Million USD | -108.5% |
| Neurogene Inc. | -52.28 Million USD | -523.964% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -139.026% |
| AEON Biopharma, Inc. | -48.36 Million USD | -574.606% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -250.734% |
| Sesen Bio, Inc. | -50.84 Million USD | -541.711% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -298.191% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -2541.663% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 23.673% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -210.129% |
| Athira Pharma, Inc. | -116.7 Million USD | -179.552% |
| Vaccinex, Inc. | -19.74 Million USD | -1552.046% |
| HCW Biologics Inc. | -23.57 Million USD | -1283.802% |
| XOMA Corporation | -39.36 Million USD | -728.835% |
| Nektar Therapeutics | -243.1 Million USD | -34.199% |
| Arvinas, Inc. | -394.8 Million USD | 17.364% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 172985.865% |
| Merus N.V. | -149.2 Million USD | -118.653% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -248.964% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -943.653% |
| Rezolute, Inc. | -68.42 Million USD | -376.808% |
| Clene Inc. | -43.24 Million USD | -654.483% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2015.432% |
| BeyondSpring Inc. | -21.54 Million USD | -1414.605% |
| Synlogic, Inc. | -55.16 Million USD | -491.443% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -2600.041% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -2965.646% |
| Peak Bio, Inc. | -1356.23 USD | -24055259.342% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -904.916% |
| Krystal Biotech, Inc. | 17.9 Million USD | 1922.196% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -175.492% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 4.424% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -6982.401% |
| MannKind Corporation | 15.12 Million USD | 2256.428% |
| Ikena Oncology, Inc. | -74.39 Million USD | -338.52% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -2490.693% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 1704.988% |
| Gossamer Bio, Inc. | -172.15 Million USD | -89.51% |
| CohBar, Inc. | -12.06 Million USD | -2603.9% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1178.945% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -986.581% |
| Legend Biotech Corporation | -477.87 Million USD | 31.73% |
| Mural Oncology plc | -192.72 Million USD | -69.285% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -186.045% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -1920.691% |
| Disc Medicine, Inc. | -91.02 Million USD | -258.414% |
| Champions Oncology, Inc. | -5.05 Million USD | -6355.204% |
| REGENXBIO Inc. | -239.46 Million USD | -36.24% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -2943.854% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -485.132% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -741.528% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -189.21% |
| Vaxart, Inc. | -74.72 Million USD | -336.607% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -826.617% |
| Cellectis S.A. | -98.09 Million USD | -232.582% |
| Longeveron Inc. | -20.06 Million USD | -1526.351% |
| Repare Therapeutics Inc. | -114.27 Million USD | -185.497% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 25.717% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -336.088% |
| Revolution Medicines, Inc. | -430.58 Million USD | 24.231% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -5087.566% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -959.619% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -337.386% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 6754.008% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -2875.34% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 107.084% |
| Denali Therapeutics Inc. | -179.97 Million USD | -81.275% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -342566.583% |
| Veru Inc. | -89.97 Million USD | -262.594% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1113.803% |
| Cingulate Inc. | -22.95 Million USD | -1321.425% |
| Passage Bio, Inc. | -98.34 Million USD | -231.75% |
| Context Therapeutics Inc. | -25.06 Million USD | -1201.83% |
| Exicure, Inc. | -15.53 Million USD | -1999.53% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -58.323% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -782.318% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -5371.543% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -93.659% |
| Nuvalent, Inc. | -149.49 Million USD | -118.236% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -3911.674% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -279.824% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -981.072% |
| OmniAb, Inc. | -49.73 Million USD | -556.021% |
| Anew Medical, Inc. | -1.3 Million USD | -24979.641% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -2538.677% |
| Lipocine Inc. | -16.32 Million USD | -1898.73% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -389.345% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -339.075% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -755.543% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -736.228% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -1370.703% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 40.146% |
| Ocugen, Inc. | -64.82 Million USD | -403.256% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -252.432% |
| Q32 Bio Inc. | -86.5 Million USD | -277.154% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -1827.37% |
| Alumis Inc. Common Stock | -156.89 Million USD | -107.946% |
| Equillium, Inc. | -12.13 Million USD | -2587.807% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -457.953% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -4027.946% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1629.741% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -598.719% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -206.781% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -1723.97% |
| Dominari Holdings Inc. | -22.44 Million USD | -1353.859% |
| Edesa Biotech, Inc. | -8.19 Million USD | -3883.399% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1183.827% |
| Bio-Techne Corporation | 326.66 Million USD | 199.872% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 15.231% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 250.768% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -148.838% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -771.593% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -115.913% |
| Nkarta, Inc. | -120.48 Million USD | -170.786% |
| BioCardia, Inc. | -11.56 Million USD | -2722.197% |
| Iterum Therapeutics plc | -34.58 Million USD | -843.453% |